Abiopharma

AMPLIFY ENERGY CORP. (AMPY) Reports the reporting period Financial Results AMPLIFY ENERGY CORP. (AMPY) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 11
• Net Income: (1,740)
• EPS: $000
• Cash and equivalents: 21212
  • 0 million of Amplify’s common stock◾Using recent prices, a fully executed program would represent approximately 10% of outstanding sharesoContinued the development program at Beta, drilling two additional wells with promising initial results:◾Completed the C29 well in June with a peak IP30 of approximately 525 Bopd◾Completed the C16 well in July with a peak IP30 of approximately 550 Bopd●During the second quarter of 2026, the Company:oAveraged total production of
  • 8 Mbopd (100% oil), an increase of approximately 6% compared to the prior quarteroReported net income of $
  • 3 million in the second quarter compared to a net loss of $
    • targeting the D Sand reservoir. The C29 well was completed in June and achieved a peak IP30 rate of approximately 525 Bopd, while the C16 well was completed in July and delivered a peak IP30 rate of approximately 550 Bopd. At current commodity prices, Amplify expects both wells to achieve payout in approximately 15 months and generate an internal rate of return (IRR) of approximately 100%.​Early production performance from both wells remains consistent with the Company's established type curves. These results further demonstrate the quality, predictability, and repeatability of the D Sand development program and reinforce management's confidence in the field's remaining drilling inventory and future development potential.​In addition to the contribution from new wells, Beta began benefiting from royalty relief during the second quarter following the May 1, 2026